Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2pos DCIS Independent of Route: Results of Randomized Selection …
L Lowenfeld, R Mick, J Datta, S Xu, E Fitzpatrick… - Clinical cancer …, 2017 - AACR
Purpose: Vaccination with HER2 peptide-pulsed DC1s stimulates a HER2-specific T-cell
response. This randomized trial aimed to establish safety and evaluate immune and clinical …
response. This randomized trial aimed to establish safety and evaluate immune and clinical …
Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2pos DCIS Independent of Route: Results of Randomized Selection Design …
L Lowenfeld, R Mick, J Datta, S Xu, E Fitzpatrick… - Clinical Cancer …, 2017 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Purpose: Vaccination with HER2 peptide-
pulsed DC1s stimulates a HER2-specific T-cell response. This randomized trial aimed to …
pulsed DC1s stimulates a HER2-specific T-cell response. This randomized trial aimed to …
Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2 (pos) DCIS Independent of Route: Results of Randomized Selection …
L Lowenfeld, R Mick, J Datta, S Xu… - Clinical cancer …, 2017 - scholarship.miami.edu
Purpose: Vaccination with HER2 peptide-pulsed DC1s stimulates a HER2-specific T-cell
response. This randomized trial aimed to establish safety and evaluate immune and clinical …
response. This randomized trial aimed to establish safety and evaluate immune and clinical …
[PDF][PDF] Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2 pos DCIS Independent of Route: Results of Randomized Selection …
L Lowenfeld, R Mick, J Datta, S Xu, E Fitzpatrick… - scholar.archive.org
Purpose: Vaccination with HER2 peptide-pulsed DC1s stimulates a HER2-specific T-cell
response. This randomized trial aimed to establish safety and evaluate immune and clinical …
response. This randomized trial aimed to establish safety and evaluate immune and clinical …
Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2pos DCIS Independent of Route: Results of Randomized Selection …
L Lowenfeld, R Mick, J Datta, S Xu… - … Cancer Research: an …, 2016 - europepmc.org
Purpose: Vaccination with HER2 peptide-pulsed DC1s stimulates a HER2-specific T-cell
response. This randomized trial aimed to establish safety and evaluate immune and clinical …
response. This randomized trial aimed to establish safety and evaluate immune and clinical …
[PDF][PDF] Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2 pos DCIS Independent of Route: Results of Randomized Selection …
L Lowenfeld, R Mick, J Datta, S Xu, E Fitzpatrick… - immunorestoration.com
Purpose: Vaccination with HER2 peptide-pulsed DC1s stimulates a HER2-specific T-cell
response. This randomized trial aimed to establish safety and evaluate immune and clinical …
response. This randomized trial aimed to establish safety and evaluate immune and clinical …
Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2pos DCIS Independent of Route: Results of Randomized Selection Design …
L Lowenfeld, R Mick, J Datta, S Xu, E Fitzpatrick… - 2017 - pubmed.ncbi.nlm.nih.gov
Purpose: Vaccination with HER2 peptide-pulsed DC1s stimulates a HER2-specific T-cell
response. This randomized trial aimed to establish safety and evaluate immune and clinical …
response. This randomized trial aimed to establish safety and evaluate immune and clinical …